This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of ropinirole
PDMED_ROPINIROLE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1423 |
4. Check minimum number of events
Min. number of events
3
|
1423 |
5. Include endpointsNone |
1423 |
6. Filter based on genotype QC (FinnGen only) |
1264 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of ropinirole
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1264 | 582 | 682 |
| Unadjusted period prevalence (%) | 0.26 | 0.21 | 0.31 |
| Median age at first event (years) | 64.08 | 63.57 | 64.51 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1298
- Matched controls
- 12980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N87
ICPC
Parkinsonism
160.0
307.7
574
64
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
129.1
307.7
188
17
N04BC04
ATC
ropinirole; oral
+∞
307.7
1298
7
193
Kela drug reimbursment
Rasagiline
267.9
307.7
352
18
N04BD01
ATC
selegiline; oral
322.2
307.7
686
45
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
219.7
307.7
525
40
N04BD02
ATC
rasagiline; oral
277.8
307.7
441
24
N04BC05
ATC
pramipexole; oral
18.6
307.7
611
592
G20
ICD-10 Finland
Parkinson disease
357.7
307.7
1071
169
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
266.8
307.7
1058
211
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
398.9
307.7
1075
155
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
143.7
282.1
141
11
R25.1
ICD-10 Finland
Tremor, unspecified
15.5
281.1
265
211
N04BC09
ATC
rotigotine; transdermal
440.9
254.3
247
7
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
30.4
207.6
139
51
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
105.9
207.5
107
11
N03AE01
ATC
clonazepam; systemic
8.9
197.7
277
382
N06DA03
ATC
rivastigmine; oral, transdermal
9.4
194.1
258
333
N04BB01
ATC
amantadine; oral
23.2
192.6
143
69
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
11.7
170.3
186
183
N04BX02
ATC
entacapone; oral
341.0
151.1
150
5
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
39.5
149.6
92
25
N05AH04
ATC
quetiapine; oral
4.7
141.6
444
1295
G04BD12
ATC
mirabegron; oral
4.2
115.3
396
1216
N04BX04
ATC
opicapone; oral
159.0
111.2
116
8
N04AA02
ATC
biperiden; systemic
12.8
109.4
109
92
XA800
NOMESCO Finland
Neuropsychological investigation
7.4
104.9
163
247
N04BC06
ATC
cabergoline; oral
39.1
79.6
49
13
N19
ICPC
Speech disorder
11.1
70.4
76
72
C07AA05
ATC
propranolol; systemic
3.1
70.0
386
1553
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
29.8
69.0
46
16
R1250
NOMESCO Finland
Evaluation of functional capability
7.1
68.4
107
162
SPAT1229
SPAT
Assessment of need for aid
3.9
62.3
208
606
L28
ICPC
Limited function/disability (L)
2.8
61.2
422
1899
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
12.8
60.2
59
48
N03AX12
ATC
[U] gabapentin; oral
2.9
59.9
354
1465
R4130
NOMESCO Finland
Speech therapy
6.6
58.4
97
156
XF606
NOMESCO Finland
Ortostatic test
12.5
54.2
54
45
H02AA02
ATC
fludrocortisone; oral
14.2
52.1
48
35
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
51.9
223
762
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
48.1
529
2911
AA1AD
NOMESCO Finland
CT of head and brain
2.3
46.1
562
3218
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
227.5
43.2
44
*
Z2445
NOMESCO Finland
Psychologist
5.5
43.1
86
165
A28
ICPC
Limited function/disability NOS
2.4
42.5
372
1832
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
8.1
42.0
57
73
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
41.3
296
1326
I95.1
ICD-10 Finland
Orthostatic hypotension
4.2
40.9
116
298
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
39.3
106
262
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.8
38.6
91
202
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
37.6
176
627
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
36.5
178
649
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
36.1
136
424
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
35.6
308
1495
M48.0
ICD-10 Finland
Spinal stenosis
2.5
35.2
273
1260
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.3
35.1
145
479
SPAT1216
SPAT
Assessment of functional ability
2.4
34.1
304
1492
N06AX11
ATC
mirtazapine; oral
2.1
33.8
527
3226
R53
ICD-10 Finland
Malaise and fatigue
2.2
33.0
399
2215
N28
ICPC
Limited function/disability (N)
5.7
32.8
62
113
R5110, ,
SPAT
2.7
32.3
196
802
A06AD11
ATC
lactulose; oral
2.4
31.9
275
1326
R47.1
ICD-10 Finland
Dysarthria and anarthria
7.2
30.2
45
64
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.2
29.9
62
123
D21
ICPC
Swallowing problem
6.0
29.8
53
91
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
29.3
352
1936
U04
ICPC
Incontinence urine
3.0
29.2
141
509
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
28.9
183
762
SPAT1234
SPAT
Support of social functional capacity
3.3
28.4
114
369
R1260
NOMESCO Finland
Evaluation of communicative skills
5.6
28.4
54
99
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
27.8
158
623
N02BF01
ATC
gabapentin; oral
2.5
27.4
204
917
G02CB01
ATC
bromocriptine; systemic
7.8
27.3
38
50
N06AB10
ATC
escitalopram; oral
2.2
27.2
272
1387
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
27.2
272
1388
R35
ICD-10 Finland
Polyuria
2.8
27.1
153
601
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
27.0
501
3198
N03AX16
ATC
[U] pregabalin
2.0
26.7
377
2190
N05BA04
ATC
oxazepam; oral
2.0
26.4
393
2324
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.4
26.3
68
162
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
25.7
140
539
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.0
25.3
121
434
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
24.7
144
574
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.2
24.5
104
348
R44.1
ICD-10 Finland
Visual hallucinations
9.8
24.2
28
29
G25.2
ICD-10 Finland
Other specified forms of tremor
8.6
24.1
31
37
N04BC07
ATC
apomorphine; parenteral
+∞
24.0
23
*
N04BC02
ATC
pergolide; oral
244.3
23.7
24
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.4
23.1
85
260
R60.0
ICD-10 Finland
Localized oedema
2.2
23.1
232
1179
G25.0
ICD-10 Finland
Essential tremor
3.8
22.8
70
190
S01.0
ICD-10 Finland
Open wound of scalp
2.5
22.4
154
665
AA5QN, ,
NOMESCO Finland
+∞
21.9
21
*
R1430, ,
SPAT
6.0
21.9
39
67
N29
ICPC
Neurological sympt/complt other
4.5
21.7
53
121
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.7
21.3
118
457
SPAT1301
SPAT
No procedures
1.8
20.4
456
3023
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
22.8
20.4
29
13
R4110, ,
SPAT
2.1
20.3
238
1280
N06AX21
ATC
duloxetine; oral
2.2
20.0
187
920
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.6
20.0
67
193
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.6
19.9
38
70
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.6
19.7
47
105
R4130, ,
SPAT
19.7
19.5
29
15
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
22.0
19.5
28
13
M41.9
ICD-10 Finland
Scoliosis, unspecified
5.6
19.4
37
68
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.1
18.8
40
81
N02BF02
ATC
pregabalin; oral
2.6
18.7
116
476
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
192.7
18.6
19
*
A04
ICPC
Weakness/tiredness general
2.0
18.0
236
1316
N04
ICPC
Restless legs
13.9
17.8
30
22
R1100, ,
SPAT
4.9
17.6
39
82
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
182.4
17.6
18
*
N30.0
ICD-10 Finland
Acute cystitis
2.0
17.5
235
1319
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
15.9
17.5
28
18
R1250, ,
SPAT
3.3
17.3
66
207
D12
ICPC
Constipation
2.9
17.1
80
283
K02.1
ICD-10 Finland
Caries of dentine
1.6
16.9
730
5686
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
16.7
172
878
L03
ICPC
Low back symptom/complaint
1.7
16.5
400
2683
SPAT1172
SPAT
Guidance concerning hydration
4.0
15.9
45
115
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
13.1
15.7
27
21
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
26.6
15.6
21
8
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.2
15.2
145
717
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
20.3
15.1
22
11
W19
ICD-10 Finland
Unspecified fall
2.1
15.1
153
775
F0232, G20,
ICD-10 Finland
57.4
14.8
17
*
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
14.7
256
1556
F0230, G20,
ICD-10 Finland
+∞
14.6
14
*
M54.5
ICD-10 Finland
Low back pain
1.6
14.6
478
3440
G04BD08
ATC
solifenacin; oral
2.3
14.6
117
539
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.5
14.5
51
152
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
14.2
246
1490
N06AX16
ATC
venlafaxine; oral
1.9
14.1
184
1019
R4120, ,
SPAT
4.4
14.1
35
81
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
14.1
132
648
H50.52
ICD-10 Finland
Exophoria
5.5
14.0
27
50
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
5.5
14.0
27
50
AXX01
NOMESCO Finland
Memory assessment
5.9
14.0
25
43
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.4
13.9
50
151
SFA10
NOMESCO Finland
One-surface restoration
1.6
13.8
684
5398
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
13.7
62
215
N08
ICPC
Abnormal involuntary movements
14.9
13.6
22
15
R23
ICPC
Voice symptom/complaint
3.7
13.5
43
120
C03CA01
ATC
furosemide; systemic
1.6
13.2
454
3286
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.3
13.2
107
495
K59.0
ICD-10 Finland
Constipation
2.4
13.1
97
431
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
12.9
221
1333
R1420, ,
SPAT
11.7
12.8
23
20
G04BD09
ATC
trospium; oral
3.3
12.8
48
149
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
12.8
98
443
M79.6
ICD-10 Finland
Pain in limb
1.5
12.7
582
4484
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.9
12.7
174
978
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
12.6
378
2644
L17
ICPC
Foot/toe symptom/complaint
1.6
12.5
428
3086
F05.9
ICD-10 Finland
Delirium, unspecified
3.4
12.5
45
136
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.6
12.5
72
285
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
131.2
12.5
13
*
Z50.5
ICD-10 Finland
Speech therapy
5.1
12.4
26
52
N86
ICPC
Multiple sclerosis
13.3
12.4
21
16
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.2
12.4
33
81
G04BD11
ATC
fesoterodine; oral
3.0
12.3
53
179
S72.0
ICD-10 Finland
Fracture of neck of femur
2.6
12.2
70
276
XKD00
NOMESCO Finland
Uroflowmetry
1.7
12.2
263
1690
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
5.0
12.2
26
53
EBA00
NOMESCO Finland
Extraction of tooth
1.5
12.1
468
3464
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
4.7
11.9
27
58
G90.3
ICD-10 Finland
Multi-system degeneration
47.1
11.9
14
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
11.9
182
1060
SFA20
NOMESCO Finland
Two-surface restoration
1.5
11.7
705
5721
U07
ICPC
Urine symptom/complaint other
2.0
11.7
134
708
AA1AA
NOMESCO Finland
Head X-ray examination
5.0
11.7
25
51
N04BC01
ATC
bromocriptine; oral
65.6
11.6
13
*
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
11.6
94
435
M03BX01
ATC
baclofen; systemic
3.5
11.6
40
118
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.3
11.6
23
44
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
13.8
11.5
19
14
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
11.4
165
942
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
121.1
11.4
12
*
S20.2
ICD-10 Finland
Contusion of thorax
2.3
11.4
83
367
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
11.3
301
2037
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
11.1
236
3502
R41.0
ICD-10 Finland
Disorientation, unspecified
2.8
11.1
56
207
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
10.1
11.0
21
21
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
11.0
779
6499
N06AX26
ATC
vortioxetine; oral
2.3
11.0
88
405
RF120, ,
NOMESCO Finland
4.6
11.0
26
58
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
10.8
865
7385
G25
ICD-10 Finland
Other extrapyramidal and movement disorders
28.3
10.7
14
5
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.7
308
2124
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
10.6
187
1133
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
3.2
10.6
41
130
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.8
10.6
54
201
K08.3
ICD-10 Finland
Retained dental root
2.0
10.5
124
663
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.3
10.4
79
355
N02AA05
ATC
oxycodone; systemic
1.6
10.4
284
1931
J01EA01
ATC
trimethoprim; systemic
1.6
10.4
307
2127
SPAT1310
SPAT
Counselling related to known health issue
1.5
10.4
406
2993
N02BE01
ATC
paracetamol; systemic, rectal
1.9
10.3
1172
10800
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
10.3
137
762
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.8
10.3
23
49
RF420, ,
NOMESCO Finland
3.9
10.2
29
75
RF410, ,
NOMESCO Finland
4.3
10.1
26
62
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.0
10.1
43
145
SCA02
NOMESCO Finland
Preventive oral health care
2.0
10.0
109
565
WX290
NOMESCO Finland
Other blockage of nerve
1.5
9.9
526
4117
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.1
9.8
40
131
A01
ICPC
Pain general/multiple sites
1.8
9.8
149
864
L29
ICPC
Musculoskeletal sympt/complt other
1.9
9.8
133
745
SPAT1254
SPAT
Administration of medicine
1.7
9.7
193
1209
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
9.6
61
253
SPF03
NOMESCO Finland
Impression for dental prosthesis repair, demanding
4.3
9.6
24
56
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.4
9.5
34
103
N99
ICPC
Neurological disease other
3.7
9.5
29
79
R2130, ,
SPAT
3.7
9.5
29
79
P03
ICPC
Feeling depressed
2.1
9.5
93
465
K11.72
ICD-10 Finland
Xerostomia
30.3
9.4
12
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
9.3
193
1223
M43.1
ICD-10 Finland
Spondylolisthesis
2.4
9.1
63
272
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
9.1
354
2593
A03FA01
ATC
metoclopramide; systemic, rectal
0.5
9.1
120
2038
WYA20, ,
SPAT
5.1
9.1
19
38
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.7
9.1
49
188
N05CF01
ATC
zopiclone; oral
1.5
9.1
414
3132
R5130, ,
SPAT
11.6
9.1
16
14
R2110
NOMESCO Finland
Giving the first information
2.2
9.0
78
372
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.9
8.8
19
39
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.3
8.8
67
302
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.1
8.8
24
60
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
8.8
87
437
R44.3
ICD-10 Finland
Hallucinations, unspecified
7.2
8.7
20
28
Y94.0
ICD-10 Finland
Accident at home
3.2
8.7
33
104
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
16.4
8.6
13
8
SPAT1263
SPAT
Sampling
1.4
8.5
506
4015
XKC03
NOMESCO Finland
Water cystometry
2.6
8.5
49
195
SPAT1260
SPAT
Consultation of another employee
1.6
8.5
229
1548
A46
ICD-10 Finland
Erysipelas
1.6
8.4
209
1383
R13
ICD-10 Finland
Dysphagia
1.9
8.4
108
593
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
2.5
8.4
52
214
L76
ICPC
Fracture: other
2.5
8.4
51
208
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.9
8.4
38
133
M01AH05
ATC
etoricoxib; oral
1.4
8.4
770
6586
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.4
8.3
55
234
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.7
8.2
43
163
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
33.6
8.1
10
*
130
Kela drug reimbursment
Malignant tumour
0.4
8.1
31
835
K07
ICPC
Swollen ankles/oedema
2.0
8.0
83
423
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.0
8.0
85
437
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.7
7.8
42
161
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.3
7.8
28
85
WZC00, ,
SPAT
1.6
7.8
193
1275
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.8
501
4011
S51.0
ICD-10 Finland
Open wound of elbow
3.7
7.8
24
66
SPAT1101
SPAT
Orthostatic test
2.2
7.7
66
313
UKC02
NOMESCO Finland
Cystoscopy
1.5
7.7
232
1605
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.6
354
2672
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.6
551
4499
R5140, ,
SPAT
3.3
7.5
27
82
M03BX02
ATC
tizanidine; oral
1.4
7.5
732
6267
N04BA07
ATC
foslevodopa and decarboxylase inhibitor; parenteral
80.5
7.4
8
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
80.5
7.4
8
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.3
7.4
27
83
H50.31
ICD-10 Finland
Intermittent exotropia
7.7
7.4
16
21
N06AB04
ATC
citalopram; systemic
1.5
7.3
244
1723
N04BX01
ATC
tolcapone; oral
+∞
7.3
7
*
Z3226
NOMESCO Finland
Physiotherapist
1.5
7.2
230
1608
RF433, ,
NOMESCO Finland
30.2
7.2
9
*
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
20.1
7.1
10
5
G21.8
ICD-10 Finland
Other secondary parkinsonism
20.1
7.1
10
5
S18
ICPC
Laceration/cut
1.4
7.0
643
5426
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
7.0
168
1100
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
3.1
7.0
28
91
SPAT1053
SPAT
Memory test
1.5
7.0
209
1440
S01.8
ICD-10 Finland
Open wound of other parts of head
3.2
7.0
27
86
XQ855, ,
SPAT
3.5
7.0
23
66
S70.0
ICD-10 Finland
Contusion of hip
2.2
7.0
59
279
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
7.0
188
1267
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
4.4
7.0
17
39
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.9
869
7703
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.4
6.9
324
2445
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.6
6.8
155
1002
SPAT1167
SPAT
Insertion of urinary catheter
2.3
6.8
51
229
R42
ICD-10 Finland
Dizziness and giddiness
1.4
6.8
304
2271
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
6.8
275
2016
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.1
6.8
64
316
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
2.8
6.7
33
121
SPAT1125
SPAT
Stoma care and guidance
3.0
6.7
29
99
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
6.7
645
5471
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
6.7
51
231
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
6.7
115
691
S20
ICPC
Corn/callosity
2.6
6.6
37
145
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
7.8
6.6
14
18
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
5.9
6.6
17
29
SFA30
NOMESCO Finland
Three-surface restoration
1.4
6.6
521
4283
R30.1
ICD-10 Finland
Vesical tenesmus
2.7
6.6
35
134
H53.2
ICD-10 Finland
Diplopia
2.3
6.6
49
220
ZX120, ,
SPAT
3.4
6.6
23
69
J01DB01
ATC
cefalexin; oral
1.4
6.5
1021
9339
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
6.5
152
989
SPAT1360
SPAT
Extensive global examination
1.8
6.5
88
492
K02
ICD-10 Finland
Dental caries
1.9
6.5
81
441
J01CA08
ATC
pivmecillinam; oral
1.4
6.5
399
3148
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
6.5
134
846
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
6.5
255
1860
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
6.5
106
629
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
6.5
169
1131
F0234, G20,
ICD-10 Finland
70.2
6.4
7
*
P01
ICPC
Feeling anxious/nervous/tense
1.9
6.4
85
473
S97
ICPC
Chronic ulcer skin
1.8
6.4
98
571
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
6.3
176
1193
WX725
NOMESCO Finland
Noninvasive ventilation
1.9
6.3
82
453
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
6.0
6.3
16
27
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.3
520
4298
SPAT1244
SPAT
Occupational therapy
3.9
6.3
18
47
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
6.3
209
1474
N06AX03
ATC
mianserin; oral
2.0
6.3
65
333
WX704
NOMESCO Finland
Intubation
1.7
6.3
106
635
SPAT1240
SPAT
Therapeutic discussion
1.8
6.2
97
567
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.4
6.2
41
175
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.1
6.2
59
293
G04BD04
ATC
oxybutynin; oral, transdermal
1.9
6.2
72
384
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
6.2
109
661
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.4
6.1
42
182
SPAT1312
SPAT
General health counselling
1.4
6.1
362
2835
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
6.1
182
1255
L84
ICD-10 Finland
Corns and callosities
2.1
6.1
52
248
SPAT1304
SPAT
Counselling and guidance related to ageing
1.7
6.0
104
626
S01
ICD-10 Finland
Open wound of head
3.4
6.0
21
63
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
47
50
9.72
39.95
2.2
1.3
124.76
130.04
nmol/l
0.05
21
36
625
4222
1.93
28.90
2.7
2.3
239.22
221.17
u/l
0.21
600
3995
991
7962
2.03
25.67
6.8
5.0
3650.50
1635.53
e6/l
0.36
20
117
447
2842
1.87
23.69
5.2
4.3
1.02
1.02
kg/l
3.21
301
1927
576
4028
1.77
21.84
1.8
1.8
19.23
20.19
nmol/l
0.47
523
3361
422
2779
1.77
19.08
1.8
1.8
391.34
25848081.37
pmol/l
2.11
355
2271
639
4746
1.68
18.44
5.2
4.2
0.00
0.03
estimate
3.17
141
1132
812
6437
1.70
18.17
5.3
4.2
8.52
2.52
estimate
0.31
175
1389
775
6133
1.65
16.85
5.3
7.2
1.20
1.21
mmol/l
1.32
717
5676
836
6751
1.67
16.74
5.8
8.0
1.21
1.21
mmol/l
0.14
722
5843
757
5967
1.64
16.61
2.4
2.2
88.97
95.42
pmol/l
4.20
469
3195
808
6479
1.65
16.52
5.3
4.2
0.00
0.25
estimate
0.55
162
1291
795
6360
1.65
16.30
5.3
4.1
0.00
0.00
estimate
-0.00
169
1355
356
2363
1.70
15.01
1.9
1.8
1254.93
1179.67
nmol/l
0.90
280
1771
650
5093
1.55
13.41
5.0
4.2
41.26
60.41
ng/l
0.80
512
3969
897
7589
1.59
12.91
5.2
5.6
6.38
6.80
mmol/l
11.13
862
7279
492
3648
1.56
12.82
5.7
4.3
0.00
0.00
estimate
0.78
156
1245
734
5968
1.53
12.37
4.4
5.4
35.42
35.15
g/l
0.65
683
5617
775
6388
1.53
12.16
11.4
17.4
1.23
1.29
inr
2.79
660
5333
558
4323
1.51
11.54
4.0
3.6
40.74
82.51
e6/l
1.21
451
3348
166
948
1.86
11.50
6.0
7.2
25.59
24.53
mmol/l
4.05
157
909
493
3744
1.51
11.10
3.8
3.5
0.34
0.45
e6/l
0.83
384
2792
659
5322
1.48
10.90
3.4
3.1
129.61
153.40
ug/l
1.63
609
4882
334
2375
1.55
10.03
2.0
2.0
—
—
—
0
0
456
3464
1.49
10.00
2.5
2.3
2.75
2.88
mg/l
0.75
397
2962
405
3032
1.49
9.44
2.9
2.8
4.83
4.76
e6/l
0.05
380
2777
702
5852
1.43
9.18
2.9
3.0
—
—
estimate
—
0
0
257
1754
1.58
9.15
5.3
8.3
5.20
5.11
kpa
0.97
246
1699
257
1755
1.58
9.13
5.3
8.3
12.53
12.03
kpa
0.69
246
1701
254
1742
1.57
8.83
5.4
8.3
1.98
0.96
mmol/l
4.72
216
1446
263
1824
1.55
8.70
2.0
1.9
—
—
—
0
0
228
1547
1.57
8.27
8.6
7.8
—
—
—
0
0
247
1711
1.55
8.17
2.1
1.9
—
—
—
0
0
983
8832
1.47
7.84
4.5
4.3
15.31
14.98
pmol/l
3.43
895
8006
352
2659
1.44
7.54
1.9
1.7
1.33
1.44
mg/l
0.25
286
2101
418
3260
1.42
7.51
4.4
3.7
0.00
0.04
estimate
0.86
140
1066
319
2380
1.45
7.27
3.5
3.2
1.49
1.02
e6/l
0.85
192
1316
118
715
1.72
6.67
1.4
1.5
—
—
—
0
0
1190
11245
1.70
6.53
22.2
18.7
27.64
26.10
mg/l
0.82
1043
9445
499
4081
1.36
6.52
2.6
2.7
52.74
82.11
u/l
0.86
465
3768
538
4467
1.35
6.32
3.1
3.2
1003.94
1341.47
ng/l
1.97
459
3890
979
8922
1.40
6.13
4.5
4.7
11.40
13.21
mm/h
3.41
907
8300
220
1588
1.46
5.86
5.9
8.6
96.17
95.56
%
1.25
208
1545
391
4758
0.74
5.46
4.0
4.3
7.12
8.59
mg/mmol
0.20
247
2990
538
4588
1.29
4.84
2.7
3.6
2.34
2.35
mmol/l
1.72
495
4140
104
1553
0.64
4.56
3.3
4.4
4.04
21.62
ug/l
2.46
82
1284
1119
10579
1.42
4.51
5.8
5.4
1.92
2.00
mu/l
1.19
1020
9657
36
169
2.16
4.43
1.6
1.7
—
—
—
0
0
400
4752
0.77
4.41
3.4
3.5
7.85
7.48
mmol/l
0.97
330
3975
157
1123
1.45
4.37
3.2
3.1
153.19
213.11
ng/l
2.10
147
1036
199
1495
1.39
4.21
6.3
9.0
124.39
121.08
g/l
1.52
191
1463
156
1124
1.44
4.18
2.4
2.5
0.44
0.39
e6/l
0.18
146
1077
141
1000
1.46
4.10
1.7
1.7
—
—
—
0
0
31
143
2.20
4.01
1.4
1.7
—
—
—
0
0
274
2184
1.32
3.94
3.9
3.3
2.92
1.95
e6/l
0.88
142
1108
662
5902
1.25
3.81
2.6
2.5
—
—
—
0
0
117
1639
0.69
3.73
4.7
5.3
34.00
32.64
%
0.64
77
1055
336
2775
1.28
3.69
2.6
3.1
2.44
2.46
mmol/l
3.37
305
2504
1011
9488
1.30
3.66
6.9
9.0
80.64
80.19
u/l
0.11
946
9011
1028
10803
0.77
3.55
4.0
4.7
1.16
1.30
mmol/l
10.80
913
9804
43
236
1.85
3.50
1.5
1.4
28.04
29.95
iu/l
0.17
43
198
19
76
2.52
3.38
1.2
1.7
—
—
—
0
0
389
3302
1.25
3.37
3.8
4.4
86.78
86.68
%
0.03
376
3241
750
6832
1.23
3.35
4.9
7.1
11.32
11.74
umol/l
0.60
713
6543
269
2193
1.29
3.24
2.3
2.7
2.31
2.26
g/l
0.67
240
2035
270
2206
1.28
3.19
2.3
2.0
29.19
29.60
s
0.51
261
2140
617
5529
1.22
3.17
2.4
2.5
74.89
78.84
nmol/l
3.17
549
4916
6
199
0.30
3.08
1.0
1.7
10.86
24.41
ug/l
—
6
194
975
9184
1.25
2.97
24.8
23.3
13.61
13.79
%
4.71
966
9060
1081
11239
0.77
2.95
4.8
5.5
1.44
1.44
mmol/l
0.04
981
10297
14
335
0.41
2.93
1.3
1.3
—
—
—
0
0
160
1232
1.34
2.91
2.9
2.5
6.15
7.55
ug/l
0.68
130
1108
282
2344
1.26
2.88
2.4
2.7
12.66
12.70
umol/l
0.03
255
2188
374
3210
1.23
2.86
2.5
2.6
—
—
—
0
0
125
929
1.38
2.85
1.9
1.7
—
—
—
0
0
1090
11312
0.77
2.84
4.9
5.6
4.41
4.51
mmol/l
2.56
996
10451
1113
11517
0.76
2.80
5.6
6.5
2.56
2.60
mmol/l
0.74
1013
10597
67
448
1.52
2.67
1.1
1.3
—
—
—
0
0
175
1383
1.31
2.67
2.3
2.8
63.95
69.80
e9/l
1.51
127
1035
17
73
2.35
2.65
1.3
1.7
456.92
288.51
mu/l
0.57
12
53
9
25
3.62
2.57
2.3
2.4
—
—
—
0
0
108
799
1.38
2.55
2.5
2.6
31.52
18.91
au/ml
—
8
62
17
75
2.28
2.51
2.5
2.4
—
—
—
0
0
9
26
3.48
2.48
2.3
2.4
—
—
—
0
0
281
2374
1.23
2.47
2.3
3.4
0.83
0.82
mmol/l
1.57
266
2250
1212
11800
1.41
2.47
26.1
22.8
139.86
139.67
mmol/l
2.15
1193
11604
1213
11815
1.41
2.43
26.2
23.0
3.96
4.00
mmol/l
7.23
1195
11600
49
314
1.58
2.38
8.0
8.2
105.09
105.42
mmol/l
0.18
43
285
104
775
1.37
2.37
2.9
2.7
0.64
0.62
%
0.23
104
770
457
5101
0.84
2.36
1.9
2.0
1.19
1.34
mmol/l
4.37
383
4205
139
1084
1.32
2.35
2.5
4.3
1.22
1.22
mmol/l
0.03
107
944
36
575
0.62
2.21
2.7
3.6
40.89
2674.27
u/ml
0.89
26
497
304
2617
1.21
2.21
5.1
4.2
40.65
421.86
ng/l
12.11
258
2199
97
726
1.36
2.17
1.2
1.4
50.20
60.00
au/ml
—
5
63
1071
11075
0.81
2.12
19.6
18.4
81.80
76.29
ml/min/173m2
22.34
1026
10392
59
836
0.69
2.06
2.2
2.1
3.16
3.54
ratio
2.86
52
685
179
1470
1.25
2.04
3.0
3.7
5.82
5.83
kpa
0.03
173
1430
27
452
0.59
2.02
1.1
1.6
0.14
0.35
mg/l
3.53
12
212
87
651
1.36
1.97
2.0
1.9
2.04
1.82
ug/l
0.07
68
584
1070
11043
0.82
1.89
6.7
7.2
39.75
39.99
mmol/mol
0.44
988
10262
112
877
1.30
1.88
7.7
10.9
16.76
15.89
%
2.68
105
845
24
137
1.77
1.84
1.3
1.4
33434.58
169773.54
e6/l
1.09
19
93
160
1318
1.24
1.79
2.0
2.3
219.70
142.01
ug/g
0.99
135
1053
748
7025
1.15
1.77
8.4
10.1
4.24
4.21
e9/l
0.11
645
6076
90
692
1.32
1.73
5.8
5.5
1.47
1.59
%
1.19
83
656
47
324
1.47
1.71
1.1
1.1
—
—
—
0
0
48
333
1.46
1.70
1.6
1.6
—
—
—
0
0
47
325
1.46
1.69
1.1
1.1
—
—
—
0
0
41
594
0.68
1.66
1.7
1.8
2.91
3.50
mmol/l
3.67
32
443
8
173
0.46
1.58
1.0
1.0
—
—
—
0
0
939
9000
1.16
1.57
29.0
24.7
331.48
331.94
g/l
0.88
933
8956
19
320
0.59
1.52
1.5
1.5
—
—
—
0
0
236
2056
1.18
1.50
2.4
2.7
22.45
22.57
%
0.04
211
1921
9
38
2.38
1.45
1.3
1.1
—
—
—
0
0
21
337
0.62
1.40
1.9
2.5
285.85
105.92
ug/min
0.35
13
200
20
324
0.61
1.39
1.2
1.3
—
—
—
0
0
1223
12025
1.30
1.38
27.6
25.1
73.85
81.56
umol/l
19.70
1210
11901
25
160
1.57
1.32
1.4
1.4
—
—
—
0
0
0
41
0.00
1.31
0.0
1.3
—
9.31
—
0
41
11
205
0.53
1.28
1.1
1.1
—
—
—
0
0
50
373
1.35
1.24
1.8
1.5
—
—
—
0
0
86
695
1.25
1.20
1.5
1.3
273.42
220.88
u/ml
0.29
79
642
276
2478
1.14
1.20
1.3
1.3
1.03
1.66
u/ml
1.12
75
656
28
405
0.68
1.19
1.8
1.8
—
—
—
0
0
452
4190
1.12
1.18
4.7
4.9
21.65
21.44
%
0.12
233
2177
163
1409
1.18
1.16
4.4
3.7
—
—
—
0
0
164
1419
1.18
1.16
2.9
3.7
2.40
1.94
mmol/l
0.85
145
1217
21
134
1.58
1.14
2.2
3.0
20.57
11.08
index
—
7
83
5
111
0.45
1.13
1.0
1.3
—
—
—
0
0
17
269
0.63
1.11
1.2
1.6
0.77
0.86
nmol/l
0.34
12
223
59
460
1.30
1.11
1.2
1.3
—
—
—
0
0
9
164
0.55
1.08
1.2
1.5
—
—
—
0
0
9
164
0.55
1.08
1.2
1.5
—
—
—
0
0
9
165
0.54
1.08
1.2
1.5
—
—
—
0
0
51
392
1.31
1.07
1.6
1.6
24.14
20.98
u/ml
0.09
12
64
47
357
1.33
1.06
1.8
1.6
—
—
—
0
0
124
1056
1.19
1.06
3.3
3.0
67.62
62.40
ml/min/173m2
0.62
52
459
7
33
2.13
1.05
1.4
1.1
—
—
—
0
0
48
369
1.31
1.01
3.8
3.3
2.00
1.91
index
0.03
21
206
5
108
0.46
1.01
1.4
2.3
407.80
628.76
ml
—
5
68
16
99
1.62
1.00
1.3
1.1
103.69
106.13
pmol/l
0.08
16
99
15
92
1.64
0.97
1.3
1.4
—
—
—
0
0
15
92
1.64
0.97
1.3
1.4
—
—
—
0
0
13
77
1.70
0.95
2.0
1.9
—
—
—
0
0
238
2158
1.13
0.90
1.3
1.3
21.89
37.39
iu/ml
2.58
62
685
8
42
1.91
0.88
3.1
2.3
29.89
213.48
ug/l
—
8
35
32
237
1.36
0.88
1.1
1.3
12.77
9.22
u/l
0.59
27
186
28
380
0.73
0.88
1.9
2.0
100.46
90.11
%
1.64
28
367
14
87
1.62
0.87
1.0
1.5
—
351.25
—
0
8
8
43
1.87
0.87
1.1
1.1
—
—
—
0
0
10
168
0.59
0.87
1.2
1.5
—
—
—
0
0
10
168
0.59
0.87
1.2
1.5
—
—
—
0
0
10
167
0.60
0.85
1.3
1.4
5.69
6.66
mmol/l
—
10
157
10
166
0.60
0.83
1.2
1.5
—
—
—
0
0
143
1262
1.15
0.83
2.0
3.1
65.97
66.42
g/l
0.28
119
1171
288
3115
0.90
0.81
3.3
3.4
0.66
0.76
ug/l
2.82
198
2142
39
495
0.78
0.78
2.4
3.8
1.46
3.11
ratio
1.40
21
286
15
99
1.52
0.75
1.3
1.8
1.00
1.57
u/field
—
8
54
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
1224
12115
1.18
0.69
32.3
28.4
91.46
91.66
fl
0.94
1209
11983
1224
12115
1.18
0.69
32.5
28.5
242.54
243.37
e9/l
0.18
1204
11868
1105
11221
0.90
0.69
5.3
5.8
5.93
6.05
mmol/l
3.39
991
10201
1224
12117
1.18
0.68
32.8
29.1
39.52
40.18
%
4.47
1209
11979
1224
12117
1.18
0.68
32.4
28.4
4.38
4.45
e12/l
6.15
1200
11825
18
127
1.42
0.68
1.2
1.1
0.80
1.18
u/ml
—
8
69
1224
12119
1.18
0.66
32.7
28.7
131.64
134.57
g/l
10.43
1208
11988
122
1085
1.14
0.66
2.5
4.0
88.11
94.87
ng/l
0.33
103
938
78
671
1.17
0.66
2.9
3.6
4.40
4.41
pmol/l
0.02
71
595
47
385
1.23
0.66
1.8
1.6
12356.09
14929.93
e6/l
0.13
35
270
12
78
1.54
0.65
1.3
1.4
75.67
86.12
umol/l
0.78
12
78
106
1198
0.87
0.65
1.6
1.8
1.43
1.57
%
2.06
93
1002
119
1333
0.88
0.64
4.4
7.5
9.63
10.43
mmol/l
0.66
109
1289
33
261
1.27
0.63
1.4
1.3
—
—
—
0
0
103
911
1.14
0.62
5.7
8.8
25.54
24.96
mmol/l
1.08
103
906
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
521
0.82
0.61
2.0
2.6
0.44
0.36
iu/ml
0.83
22
287
16
221
0.72
0.60
2.8
4.5
1.94
1.54
%
0.12
16
205
1223
12117
1.16
0.60
32.4
28.5
6.59
6.80
e9/l
3.27
1199
11825
26
333
0.78
0.60
4.7
3.4
0.75
0.82
nmol/l
0.61
19
272
7
112
0.62
0.58
1.0
1.1
—
—
—
0
0
162
1480
1.11
0.58
1.9
2.9
6.45
8.24
umol/l
0.93
137
1333
74
645
1.16
0.55
4.1
3.8
1.02
1.02
ratio
0.96
64
600
32
257
1.25
0.55
1.1
1.3
—
372.50
—
0
8
45
376
1.20
0.55
1.3
1.4
—
—
—
0
0
12
171
0.70
0.55
3.4
2.3
0.96
0.44
mmol/l
0.20
12
165
76
665
1.15
0.54
3.3
3.4
25.80
25.23
mmol/l
0.94
70
642
29
360
0.80
0.53
1.9
1.7
1.74
3.88
mg/l
2.48
24
283
424
4051
1.07
0.53
3.2
3.4
27.59
34.06
u/l
5.44
400
3816
11
158
0.69
0.53
7.6
4.2
—
—
—
0
0
18
237
0.76
0.52
1.1
1.4
—
20.76
—
0
5
9
133
0.67
0.52
1.0
1.6
—
—
—
0
0
15
109
1.38
0.51
1.1
1.3
—
—
—
0
0
37
306
1.22
0.51
1.4
1.2
3.60
3.79
mmol/l
0.82
37
287
36
297
1.22
0.50
1.6
1.9
3.86
24.15
iu/l
0.51
18
117
41
343
1.20
0.50
2.1
2.4
128.38
128.87
g/l
0.05
32
270
160
1732
0.91
0.49
2.9
4.4
224.59
247.89
u/l
2.75
146
1657
11
155
0.71
0.48
1.2
1.1
—
—
—
0
0
44
517
0.85
0.48
3.0
3.2
26.03
25.08
mmol/l
1.02
44
510
23
289
0.79
0.48
4.0
3.6
7.16
7.75
mmol/l
0.53
23
283
38
318
1.20
0.47
1.8
2.9
28.03
32.40
umol/l
0.70
31
279
10
68
1.47
0.47
1.1
1.0
1.02
1.19
u/l
—
5
32
36
302
1.20
0.44
1.4
1.3
2.62
63.59
e6/l
1.41
29
220
10
69
1.45
0.44
1.8
1.9
—
—
—
0
0
131
1205
1.10
0.44
1.4
1.4
—
—
—
0
0
11
151
0.73
0.43
1.1
1.3
—
—
—
0
0
6
92
0.65
0.42
1.3
1.2
—
—
—
0
0
13
173
0.75
0.42
1.2
1.4
68784.29
115279.23
e6/l
—
7
97
31
258
1.21
0.42
1.1
1.3
—
276.47
—
0
17
38
323
1.18
0.41
1.3
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
8
59
1.36
0.41
1.1
1.1
—
73.44
%
—
0
9
10
71
1.41
0.39
1.1
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
10.6
—
5.33
—
0
19
11
148
0.74
0.38
3.1
4.7
61.05
56.33
%
0.35
11
132
761
7453
1.05
0.38
3.1
3.5
44.32
54.35
u/l
1.22
703
6929
9
67
1.35
0.38
2.9
2.5
470.56
1421.34
u/ml
—
9
67
45
392
1.15
0.38
1.5
1.4
—
—
—
0
0
131
1216
1.09
0.37
2.0
2.4
375.76
380.63
nmol/l
0.09
119
1127
23
189
1.22
0.36
1.2
1.7
—
—
—
0
0
9
71
1.27
0.36
1.2
1.2
—
—
—
0
0
112
1035
1.09
0.36
1.4
1.4
—
—
—
0
0
14
108
1.30
0.35
1.0
1.0
—
—
—
0
0
64
575
1.12
0.35
2.1
2.9
2.90
2.97
g/l
0.18
57
526
28
236
1.19
0.35
1.3
1.5
—
—
—
0
0
532
5175
1.05
0.35
5.3
6.0
2.41
2.73
ug/l
0.45
469
4656
48
542
0.88
0.34
2.3
4.0
33.99
59.90
mg/l
1.50
41
461
48
542
0.88
0.34
2.3
4.0
38.90
97.12
mg/l
1.07
41
463
10
133
0.75
0.33
1.3
1.2
42.80
53.45
u/l
—
10
118
116
1246
0.92
0.33
2.6
2.5
31.56
40.02
u/l
1.13
99
1042
7
53
1.32
0.31
1.3
1.0
—
—
—
0
0
49
547
0.89
0.30
2.1
2.0
33.43
39.32
u/l
1.72
39
478
18
147
1.23
0.30
2.1
2.6
—
—
—
0
0
10
75
1.34
0.30
1.5
1.5
—
—
—
0
0
10
75
1.34
0.30
1.5
1.5
—
—
—
0
0
16
196
0.81
0.30
1.3
1.3
30.20
189.03
miu/ml
—
5
71
51
458
1.12
0.30
1.1
1.2
0.26
1.07
u/ml
—
5
31
71
650
1.10
0.29
1.2
1.2
39.05
142.78
u/ml
4.46
30
239
10
130
0.77
0.29
1.1
1.2
2.82
1.47
nmol/l
—
10
116
21
249
0.84
0.29
1.3
1.3
0.86
0.92
g/l
0.88
21
249
10
129
0.77
0.28
1.2
1.1
—
55.33
—
0
9
9
116
0.77
0.27
1.6
1.4
12.44
13.01
u/l
—
9
109
9
121
0.74
0.27
1.3
1.2
7.86
7.47
mmol/l
—
9
102
12
150
0.80
0.27
1.4
1.6
32.92
34.45
ng/l
0.06
12
150
14
113
1.24
0.26
1.1
1.1
—
—
—
0
0
32
281
1.14
0.26
1.3
1.5
—
—
—
0
0
5
71
0.70
0.26
1.0
1.2
120.60
84.48
u/l
—
5
65
5
71
0.70
0.26
1.0
1.2
34.40
24.74
u/l
—
5
65
9
72
1.25
0.25
1.2
1.3
133.56
153.13
pmol/l
—
9
72
41
368
1.12
0.25
1.2
1.7
—
—
—
0
0
17
202
0.84
0.25
1.1
1.2
0.69
0.68
ratio
—
6
44
6
83
0.72
0.24
1.5
1.2
64.83
82.59
u/l
—
6
71
20
231
0.86
0.22
1.2
1.2
1.44
1.54
g/l
1.61
20
231
17
199
0.85
0.21
1.2
1.4
3581.82
5955.36
e6/l
0.22
11
141
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
8.67
—
0
6
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
5560.83
—
0
6
0
11
0.00
0.21
0.0
1.0
—
0.04
—
0
5
0
11
0.00
0.21
0.0
1.3
—
7.84
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
26
293
0.89
0.21
2.2
5.7
430.80
712.70
iu/ml
—
5
43
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
6
49
1.23
0.20
2.8
2.7
0.56
0.60
mmol/l
—
6
49
44
404
1.09
0.19
1.4
1.5
277.75
273.46
ug/g
0.05
29
250
6
51
1.18
0.19
1.0
1.4
—
—
—
0
0
31
280
1.11
0.18
1.3
1.5
—
—
—
0
0
12
100
1.20
0.18
1.1
1.5
—
21.42
—
0
12
10
121
0.83
0.18
1.3
1.2
14.30
11.80
u/l
—
10
108
28
252
1.11
0.18
4.4
3.8
41.06
27.66
mg/l
0.65
19
171
11
91
1.21
0.17
1.1
1.1
—
—
—
0
0
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
199
1931
1.04
0.16
3.2
6.1
1.02
1.03
mmol/l
0.18
183
1793
65
613
1.06
0.16
2.0
2.8
3.52
3.75
g/l
0.84
58
563
65
613
1.06
0.16
2.0
2.8
7.27
7.38
g/l
0.18
58
563
65
613
1.06
0.16
2.0
2.8
4.18
4.21
g/l
0.08
58
564
21
235
0.89
0.16
2.2
2.0
1.67
1.69
mmol/l
0.02
21
227
9
78
1.15
0.15
1.3
1.2
—
—
—
0
0
9
78
1.15
0.15
1.3
1.2
—
—
—
0
0
142
1371
1.04
0.15
1.9
2.3
0.21
0.21
g/l
0.05
129
1279
9
82
1.10
0.15
1.1
1.5
0.23
0.22
nmol/l
—
9
57
13
150
0.87
0.14
1.1
1.9
—
—
—
0
0
20
223
0.90
0.14
1.6
1.3
—
—
—
0
0
11
93
1.18
0.14
1.1
1.1
—
—
—
0
0
40
372
1.08
0.14
1.2
1.7
—
—
—
0
0
12
103
1.17
0.13
1.1
1.1
—
—
—
0
0
10
117
0.85
0.13
1.2
1.1
105.00
96.28
%
—
10
108
135
1392
0.97
0.12
1.3
1.4
—
—
—
0
0
24
262
0.91
0.12
1.1
1.2
—
55.91
—
0
28
1186
11897
0.96
0.12
12.0
13.6
19.06
25.75
u/l
62.24
1114
11542
208
2034
1.03
0.11
1.3
1.3
5.88
13.11
u/ml
1.56
80
734
53
503
1.06
0.11
1.5
1.8
6.14
7.68
iu/ml
0.34
19
119
50
474
1.06
0.11
1.8
1.9
—
—
—
0
0
54
514
1.05
0.11
1.9
2.0
—
—
—
0
0
217
2214
0.98
0.10
1.4
1.5
2.73
2.68
g/l
0.05
113
1298
44
464
0.95
0.10
1.0
1.0
—
—
—
0
0
11
96
1.15
0.10
1.1
1.1
—
—
—
0
0
11
96
1.15
0.10
1.1
1.1
—
—
—
0
0
5
44
1.14
0.10
1.2
1.1
—
—
—
0
0
5
47
1.06
0.09
1.4
1.1
127.80
233.99
iu/ml
—
5
47
43
452
0.95
0.09
1.7
1.6
—
—
—
0
0
14
126
1.11
0.09
1.1
1.7
—
—
—
0
0
14
126
1.11
0.09
1.1
1.7
—
—
—
0
0
14
126
1.11
0.09
1.1
1.7
—
—
—
0
0
22
204
1.08
0.08
1.5
1.4
—
—
—
0
0
52
542
0.96
0.08
3.7
2.6
—
—
—
0
0
5
61
0.82
0.08
1.2
1.6
2.06
11.14
nmol/l
—
5
53
16
146
1.10
0.08
1.6
1.4
—
—
—
0
0
24
256
0.94
0.08
1.3
1.9
—
—
—
0
0
6
70
0.86
0.07
1.2
2.0
—
—
—
0
0
6
70
0.86
0.07
1.2
2.0
—
—
—
0
0
6
70
0.86
0.07
1.2
2.0
—
—
—
0
0
6
70
0.86
0.07
1.2
2.0
—
—
—
0
0
6
74
0.81
0.07
1.3
1.2
8.75
9.46
mmol/l
—
6
69
8
78
1.03
0.07
1.0
1.0
—
—
—
0
0
7
81
0.86
0.07
2.4
3.5
13.44
13.27
%
—
7
81
7
83
0.84
0.07
1.1
3.2
0.71
0.90
index
—
7
83
27
256
1.06
0.06
1.3
1.4
—
—
—
0
0
27
256
1.06
0.06
1.3
1.4
—
—
—
0
0
116
1138
1.02
0.06
2.6
2.4
12.62
13.20
nmol/l
0.37
105
1017
13
141
0.92
0.05
1.1
1.9
—
—
—
0
0
56
545
1.03
0.05
2.2
3.0
0.40
1.55
g/l
2.58
45
475
73
714
1.02
0.04
1.6
1.8
1.40
1.55
g/l
0.73
62
630
47
459
1.02
0.03
2.4
2.8
0.00
0.03
g/l
1.31
40
417
10
92
1.09
0.03
1.6
1.6
—
—
—
0
0
95
963
0.99
0.03
3.5
4.0
5.14
5.16
kpa
0.11
88
925
11
102
1.08
0.03
1.2
1.2
1.95
2.01
mmol/l
0.12
11
93
34
350
0.97
0.03
3.4
3.4
1.68
1.59
mmol/l
0.20
34
343
343
3447
0.99
0.02
2.4
3.0
321.69
354.31
umol/l
8.65
292
3025
19
182
1.04
0.02
1.4
1.7
—
—
—
0
0
38
372
1.02
0.01
1.4
1.5
0.46
0.09
iu/ml
0.93
13
59
30
307
0.98
0.01
2.9
2.9
16.16
16.14
%
0.01
30
299
50
494
1.01
0.00
1.7
1.6
—
—
—
0
0
10
96
1.04
0.00
1.6
1.6
—
—
—
0
0
25
254
0.98
0.00
1.2
1.4
—
—
—
0
0
12
119
1.01
0.00
1.3
1.8
—
—
—
0
0
52
518
1.00
0.00
3.6
4.1
24.98
24.97
mmol/l
0.01
44
480
42
419
1.00
0.00
2.5
2.9
0.00
0.00
g/l
-0.00
37
397
11
107
1.03
0.00
1.5
1.6
—
—
—
0
0
19
187
1.02
0.00
1.4
1.3
0.91
0.34
nmol/l
1.83
11
15
54
537
1.01
0.00
2.2
2.9
9.33
10.58
g/l
1.69
47
485
82
825
0.99
0.00
3.3
3.8
1.93
2.01
mmol/l
0.07
63
629
0
8
0.00
0.00
0.0
1.4
—
2.50
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
67
0.90
0.00
1.8
3.0
1.00
1.16
%
—
6
67
0
7
0.00
-0.00
0.0
1.0
—
21.13
—
0
7
7
73
0.96
-0.00
1.1
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
391.20
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
89
0.90
-0.00
1.1
1.4
0.70
1.02
promille
—
8
73
0
7
0.00
-0.00
0.0
8.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
45
450
1.00
-0.00
2.4
2.8
0.00
0.00
g/l
-0.00
37
398
6
68
0.88
-0.00
1.2
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1745.20
—
0
5
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.3
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
6.37
—
0
9
6
68
0.88
-0.00
1.2
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
51.50
—
0
7
0
9
0.00
-0.00
0.0
4.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
7.46
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
39.07
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_ROPINIROLE – Use of ropinirole
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).